Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
70.53B | 72.33B | 72.92B | 62.22B | 72.81B | Gross Profit |
14.29B | 14.68B | 15.37B | 13.41B | 15.64B | EBIT |
2.49B | 2.21B | 3.67B | 1.21B | 3.04B | EBITDA |
7.15B | 4.13B | 4.90B | -7.48B | 5.03B | Net Income Common Stockholders |
3.43B | 2.07B | 11.86B | -7.92B | 1.97B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.49B | 5.69B | 9.18B | 7.60B | 6.12B | Total Assets |
129.56B | 114.36B | 113.36B | 102.70B | 106.76B | Total Debt |
36.00B | 27.26B | 25.15B | 37.61B | 30.93B | Net Debt |
26.51B | 21.56B | 15.97B | 30.00B | 24.81B | Total Liabilities |
79.92B | 68.12B | 67.94B | 65.32B | 61.35B | Stockholders Equity |
49.65B | 46.24B | 45.41B | 37.39B | 45.41B |
Cash Flow | Free Cash Flow | |||
-6.83B | -4.71B | 12.87B | -4.01B | -510.00M | Operating Cash Flow |
-5.91B | -2.91B | 14.96B | -1.43B | 1.21B | Investing Cash Flow |
1.72B | -1.45B | -15.00M | -2.78B | -2.73B | Financing Cash Flow |
7.41B | 800.00M | -13.49B | 5.57B | 2.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $909.30B | 9.91 | 14.10% | 2.39% | 1.83% | 21.82% | |
78 Outperform | ¥4.75T | 26.58 | 8.97% | 0.76% | -1.55% | 17.24% | |
77 Outperform | ¥16.77T | 27.44 | 10.50% | 1.09% | 0.56% | 5.32% | |
75 Outperform | ¥5.91T | 18.05 | 8.40% | 1.75% | 5.02% | 14.73% | |
72 Outperform | ¥30.23B | 7.57 | 8.58% | 4.31% | 20.13% | 83.20% | |
66 Neutral | ¥12.24B | 7.24 | 2.19% | 19.77% | 108.68% | ||
60 Neutral | $10.78B | 10.47 | -6.71% | 2.99% | 7.58% | -12.08% |